Big mitogen-activated protein kinase 1 protects cultured rat aortic smooth muscle cells from oxidative damage

Journal of Pharmacological Sciences

Volumn 116, Issue 2, 2011, Pages 173-180

  Zhao, Jing ^a   Kyotani, Yoji ^a   Itoh, Satoyasu ^a   Nakayama, Hitoshi ^a   Isosaki, Minoru ^a   Yoshizumi, Masanori ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis; Big mitogen activated protein kinase 1 (Bmk1); Calcification; Oxidative stress; Smooth muscle cell

Indexed keywords

4 AMINO 5 (4 CHLOROPHENYL) 7 (TERT BUTYL)PYRAZOLOL[3,4 D]PYRIMIDINE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA MEDIA; APOPTOSIS; ARTICLE; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE SILENCING; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

EID: 79959346344     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11015FP     Document Type: Article

References (37)

1. Yoshizumi M, Abe J, Tsuchiya K, Berk BC, Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci. 2003;91:172-176. (Pubitemid 36575572)
2. Higashi Y, Yoshizumi M. New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilation. J Pharmacol Sci. 2003;93:399-404. (Pubitemid 38195306)
3. Farzaneh-Far A. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15:1710.
4. Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond WS. Soft tissue calcification in chronic dialysis patients. Am J Pathol. 1977;86:403-424. (Pubitemid 8035039)
5. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apop totic bodies. Circ Res. 2000;87:1055-1062.
6. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97:2307-2315. (Pubitemid 28280384)
7. Anderson HC. Molecular biology of matrix vesicles. Clin Orthop Relat Res. 1995;314:266-280.
8. Kim KM. Apoptosis and calcification. Scanning Microsc. 1995;9:1137-1178. (Pubitemid 26088134)
9. Finkel T. Signal transduction by reactive oxygen species in nonphagocytic cells. J Leukoc Biol. 1999;65:337-340. (Pubitemid 29109705)
10. Roskoski R Jr. Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun. 2005;331:1-14.
11. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317-23321. (Pubitemid 26314775)
12. Weber DS, Taniyama Y, Rocic P, Seshiah PN, Dechert MA, Gerthoffer WT, et al. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res. 2004;94:1219-1226. (Pubitemid 38656408)
13. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996;98:2572-2579. (Pubitemid 26415078)
14. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res. 1998;83:952-959. (Pubitemid 28503085)
15. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension. 1989;13:859-864. (Pubitemid 19157981)
16. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, et al. Redox regulation of vascular smooth muscle cell differentiation. Circ Res. 2001;89:39-46. (Pubitemid 34135490)
17. Kanno S, Shouji A, Asou K, Ishikawa M. Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J Pharmacol Sci. 2003;92:166-170. (Pubitemid 36833465)
18. Lee JD, Ulevitch RJ, Han J. Primary structure of BMK1: a new mammalian map kinase. Biochem Biophys Res Commun. 1995;213:715-724.
19. Zhou G, Bao ZQ, Dixon JE. Components of a new human protein kinase signal transduction pathway. J Biol Chem. 1995;270:12665-12669.
20. von der Thüsen JH, Kuiper J, van Berkel TJ, Biessen EA. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev. 2003;55:133-166. (Pubitemid 36268401)
21. Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ, Lee JD. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature. 1998;395:713-716. (Pubitemid 28475970)
22. Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem. 1999;274:26563-26571.
23. Pi X, Yan C, Berk BC. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res. 2004;94:362-369. (Pubitemid 38240728)
24. Suzaki Y, Yoshizumi M, Kagami S, Koyama AH, Taketani Y, Houchi H, et al. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults. J Biol Chem. 2002;277:9614-9621. (Pubitemid 34953051)
25. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem. 2000;275:11706-11712. (Pubitemid 30237733)
26. Nakayama H, Zhao J, Ei-Fakhrany A, Isosaki M, Satoh H, Kyotani Y, et al. Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells. Clin Exp Pharmacol Physiol. 2009;36:1183-1185.
27. Kyotani Y, Zhao J, Tomita S, Nakayama H, Isosaki M, Uno M, et al. Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways. J Pharmacol Sci. 2010;113:161-168.
28. Izawa Y, Yoshizumi M, Ishizawa K, Fujita Y, Kondo S, Kagami S, et al. Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in plateletderived growth factor (PDGF)-induced vascular smooth muscle cell migration. Hypertens Res. 2007;30:1107-1117.
29. Sharma G, Goalstone ML. Regulation of ERK5 by insulin and angiotensin-II in vascular smooth muscle cells. Biochem Biophys Res Commun. 2007;354:1078-1083. (Pubitemid 46216245)
30. Zhao M, Liu Y, Bao M, Kato Y, Han J, Eaton JW. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases. Arch Biochem Biophys. 2002;400:199-207. (Pubitemid 34852400)
31. Abe J, Takahashi M, Ishida M, Lee JD, Berk BC. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem. 1997;272:20389-20394. (Pubitemid 27355589)
32. Rovida E, Spinelli E, Sdelci S, Barbetti V, Morandi A, Giuntoli S, et al. ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. J Immunol. 2008;180:4166-4172.
33. Cavanaugh JE, Jaumotte JD, Lakoski JM, Zigmond MJ. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J Neurosci Res. 2006;84:1367-1375. (Pubitemid 44654460)
34. Devary Y, Gottlieb RA, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell. 1992;71:1081-1091. (Pubitemid 23016544)
35. Root RK, Metcalf J, Oshino N, Chance B. H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest. 1975;55:945-955.
36. Herdegen T, Claret FX, Kallunki T, Martin-Villalba A, Winter C, Hunter T, et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci. 1998;18:5124-5135. (Pubitemid 28311930)
37. Ozawa H, Shioda S, Dohi K, Matsumoto H, Mizushima H, Zhou CJ, et al. Delayed neuronal cell death in the rat hippocampus is mediated by the mitogen-activated protein kinase signal transduction pathway. Neurosci Lett. 1999;262:57-60. (Pubitemid 29104958)